HCPLive

Dr. Poordad on Ethnic Differences in Telapravir Treatment Effect

Published Online: Friday, February 17, 2012
In this video Fred Poordad, MD, Chief of Hepatology and Liver Transplantation at the Comprehensive Transplant Center at Cedars-Sinai Medical Center evaluates the effect of race on the response to treatment and viral resistance profiles with telapravir combination therapy.

 
Comment(s)
Your comments are valuable to us. Thank you.
Sorry, you must be logged in and registered to post a comment.
Sign up for HCPLive eNewsletters
*Firstname:
*Lastname:
*Email:
*Practice Type:

Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright HCPLive 2006-2011
Intellisphere, LLC. All Rights Reserved.
 




Become a Member